13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q1 2023. See the latest, Q2 2026 →
Reported value
$350.40B
+5.9% on the quarter before
Positions
425
23 new · 34 sold out
Top 10
27.3%
of the value
Est. gain
+$22.56B
on stocks held all quarter
Est. return
+7.6%
on those stocks since Q4 2022
Positions as of Mar 31, 2023, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2022. Striped tiles are options.
Largest buys
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$4.29BNew · 0.0% → 1.2%+12,081,794 shares
- GE HealthCare~$3.56BNew · 0.0% → 1.0%+43,443,782 shares
- Intel~$1.76BNew · 0.0% → 0.5%+53,970,650 shares
- Salesforce~$1.35BAdded · 0.1% → 0.6%+6,752,734 shares
- Alphabet~$863.5MAdded · 0.9% → 1.3%+8,324,802 shares
- Mastercard~$787.6MAdded · 1.5% → 1.7%+2,167,395 shares
- Palo Alto Networks~$778.4MNew · 0.0% → 0.2%+3,897,145 shares
- Amazon~$680.9MAdded · 2.2% → 2.8%+6,592,297 shares
- BlackRock~$644.6MAdded · 0.4% → 0.5%+963,350 shares
- Nvidia~$641.6MAdded · 0.3% → 0.7%+2,309,676 shares
Largest sells
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$3.87BSold out · 1.2% → 0.0%−11,855,099 shares
- Toronto Dominion Bk Ont~$1.95BCut · 0.7% → 0.1%−32,553,717 shares
- Pnc Finl Svcs Group Inc~$1.55BCut · 0.7% → 0.1%−12,198,018 shares
- General Mtrs Co~$1.37BCut · 0.8% → 0.4%−37,342,732 shares
- Unitedhealth Group Inc~$1.15BCut · 2.8% → 2.0%−2,430,025 shares
- Freeport-McMoRan~$1.01BCut · 0.9% → 0.7%−24,722,683 shares
- Microsoft~$849.5MCut · 5.7% → 6.2%−2,946,724 shares
- Pg&E Corp~$829.7MCut · 1.0% → 0.7%−51,310,043 shares
- CrowdStrike~$786.4MCut · 0.2% → 0.0%−5,729,363 shares
- Thermo Fisher Scientific Inc~$705.7MCut · 1.2% → 1.0%−1,224,453 shares
Holdings
As of Mar 31, 2023. Changes are in shares against Dec 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −3.8% · price +20.2% | 6.2% | $21.66B | +$3.64B | ||||||||
| BroadcomCOM · shares −2.9% · price +14.7% | 3.9% | $13.58B | +$1.74B | ||||||||
| General Electric CoCOM NEW · shares +2.2% · price +14.1% | 2.8% | $9.97B | +$1.21B | ||||||||
| AmazonCOM · shares +7.5% · price +23.0% | 2.8% | $9.72B | +$1.69B | ||||||||
| Abbott LabsCOM · shares −0.5% · price −7.8% | 2.2% | $7.74B | −$651.9M | ||||||||
| Raytheon Technologies CorpCOM · shares −8.7% · price −3.0% | 2.1% | $7.21B | −$220.2M | ||||||||
| Unitedhealth Group IncCOM · shares −14% · price −10.9% | 2.0% | $7.03B | −$856.7M | ||||||||
| NetflixCOM · shares +1.9% · price +17.2% | 1.9% | $6.53B | +$938.2M | ||||||||
| MetaCL A · shares −6.5% · price +76.1% | 1.8% | $6.31B | +$2.73B | ||||||||
| MastercardCL A · shares +16% · price +4.5% | 1.7% | $5.81B | +$216.5M | ||||||||
| Canadian Nat Res LtdCOM · shares +7.2% · price −0.3% | 1.6% | $5.74B | −$18.8M | ||||||||
| Abbvie IncCOM · shares −2.7% · price −1.4% | 1.6% | $5.69B | −$80.0M | ||||||||
| Gilead Sciences IncCOM · shares +6.7% · price −3.4% | 1.4% | $4.84B | −$157.3M | ||||||||
| Philip Morris Intl IncCOM · shares −11% · price −3.9% | 1.4% | $4.78B | −$194.6M | ||||||||
| Stryker CorporationCOM · shares +14% · price +16.8% | 1.3% | $4.58B | +$576.8M | ||||||||
| Comcast Corp NewCL A · shares −1.6% · price +8.4% | 1.3% | $4.52B | +$350.5M | ||||||||
| AlphabetCAP STK CL A · shares +24% · price +17.6% | 1.3% | $4.44B | +$534.3M | ||||||||
| MicronCOM · shares +10% · price +20.7% | 1.2% | $4.31B | +$670.9M | ||||||||
| Linde PlcSHS · shares New | 1.2% | $4.29B | — | ||||||||
| AppleCOM · shares −13% · price +26.9% | 1.1% | $3.80B | +$806.1M | ||||||||
| MercadoLibreCOM · shares −2.2% · price +55.7% | 1.1% | $3.70B | +$1.32B | ||||||||
| SeaSPONSORD ADS · shares +2.8% · price +66.3% | 1.0% | $3.64B | +$1.41B | ||||||||
| GE HealthCareCOMMON STOCK · shares New | 1.0% | $3.56B | — | ||||||||
| Carrier GlobalCOM · shares −1.4% · price +10.9% | 1.0% | $3.53B | +$346.8M | ||||||||
| Eog Res IncCOM · shares +22% · price −11.5% | 1.0% | $3.50B | −$372.2M | ||||||||
| Total · 425 positions | 100% | $350.40B | +$22.56B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2022 to Q1 2023: 400 stocks held throughout, up $22.56B (+7.6%).
- Microsoft+$3.64B+20%
- Meta+$2.73B+76%
- Broadcom+$1.74B+15%
- Amazon+$1.69B+23%
- Sea+$1.41B+66%
- Oak Str Health Inc1:7 split−$253.9M−74%
- Eog Res Inc−$372.2M−11%
- American Intl Group Inc−$496.6M−20%
- Abbott Labs−$651.9M−8%
- Unitedhealth Group Inc−$856.7M−11%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |